MarketCapExport financials
1Life Healthcare (ONEM)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
1Life Healthcare Income Statement 2022-2011 | ONEM
Brief overview of revenue and earnings at 1Life Healthcare
The overview follows changes across a five-year period. Revenue at 1Life Healthcare moved from $177 million in 2017 to $1 billion in 2022. The five-year change reached +491.5%, while CAGR stood at 42.7%. Revenue growth reflects a pronounced phase of business expansion.
Gross profit changed from 56.1 million dollars to 604 million dollars (+977.4%). Direct costs grew more slowly than revenue and improved the economics of sales. The gross margin was 31.7% at the start and 57.8% at the end. A wider margin shows that the economics of the core business improved.
The operating result measured by EBITDA moved from −21.1 million dollars to −329 million dollars, or −1459%. Changes in revenue did not translate into comparable EBITDA performance. EBITDA margin was −11.9% at the start and −31.4% at the end. The business retained less EBITDA from each unit of revenue.
Across the five years, the net result shifted from −$30.8 million to −$398 million. The loss widened and increased the financial risk.
Summary assessment
The financial trajectory is weak and requires a cautious interpretation. The positive side is supported by better sales economics and a larger revenue base. The most visible risks are pressure on operating profitability, lower net income and a narrow EBITDA buffer. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.
Annual Income Statement 1Life Healthcare
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
- | 2.73 B | 5.17 B | - | - | - | - | - | - | - | - | - |
Shares |
197 M | 155 M | 118 M | 18.5 M | 16.7 M | 15 M | - | - | - | - | - | - |
Historical Prices |
- | 17.6 | 43.6 | - | - | - | - | - | - | - | - | - |
Net Income |
-398 M | -255 M | -88.7 M | -52.6 M | -44.4 M | -30.8 M | - | - | - | - | - | - |
Revenue |
1.05 B | 623 M | 380 M | 276 M | 213 M | 177 M | - | - | - | - | - | - |
Cost of Revenue |
441 M | 319 M | 235 M | 168 M | 136 M | 121 M | - | - | - | - | - | - |
Gross Profit |
- | - | 145 M | 109 M | 76.5 M | 56.1 M | - | - | - | - | - | - |
Operating Income |
-420 M | -243 M | -71.4 M | -54.1 M | -45 M | -31.8 M | - | - | - | - | - | - |
Interest Expense |
-11.7 M | -13.8 M | 13.4 M | 474 K | 804 K | 834 K | - | - | - | - | - | - |
EBITDA |
-329 M | -197 M | -49 M | -39.8 M | -35.1 M | -21.1 M | - | - | - | - | - | - |
Operating Expenses |
- | - | 217 M | 163 M | 122 M | 87.8 M | - | - | - | - | - | - |
General and Administrative Expenses |
416 M | 323 M | 157 M | 109 M | 85.8 M | 58 M | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Quarterly Income Statement 1Life Healthcare
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | 196 M | 194 M | 193 M | 192 M | 154 M | 137 M | 137 M | 134 M | 129 M | 126 M | 84.9 M | 19 M | 18.5 M | 18.4 M | 18.2 M | 18.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
- | -112 M | -93.8 M | -90.9 M | - | -78.6 M | -41.3 M | -39.3 M | -8.15 M | -16.4 M | -30.3 M | -33.9 M | -19.4 M | -15.3 M | -11.2 M | -6.67 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | 261 M | 256 M | 254 M | - | 151 M | 120 M | 121 M | 122 M | 102 M | 78 M | 78.8 M | 77.4 M | 69.6 M | 66.2 M | 63 M | 58 M | 49.8 M | 51.6 M | 53.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | 111 M | 107 M | 101 M | - | 78.4 M | 67.9 M | 70.1 M | - | 58.8 M | 53.4 M | 51.6 M | - | 41.4 M | 39.4 M | 37.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | -117 M | -97.4 M | -92.6 M | - | -72.7 M | -42.6 M | -32.4 M | -2.8 M | -10.8 M | -28.7 M | -29 M | -19 M | -15.7 M | -11.3 M | -8.16 M | -19.9 M | -8.63 M | -10.4 M | -6.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | 76 K | -3.68 M | -5.12 M | - | -4.46 M | 2.84 M | 2.84 M | - | 5.65 M | 1.98 M | 54 K | - | 107 K | 131 K | 155 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | -94 M | -75.6 M | -71.7 M | - | -60.6 M | -35.3 M | -25.8 M | -2.8 M | -5.09 M | -23.5 M | -23.8 M | -19 M | -12 M | -8.21 M | -5.46 M | -19.9 M | -8.63 M | -10.4 M | -6.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | 116 M | 92.4 M | 97 M | - | 93.1 M | 77.2 M | 64.3 M | - | 40.1 M | 38.3 M | 39.9 M | - | 27.8 M | 27 M | 22.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
The income statement is one of the three key financial reports of a company 1Life Healthcare (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Health information services industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
iCAD
ICAD
|
- | - | $ 102 M |  USA |
 |
R1 RCM
RCM
|
- | - | $ 3.81 B | USA |
 |
So-Young International
SY
|
$ 2.0 | 0.5 % | $ 156 M |  China |
 |
American Well Corporation
AMWL
|
$ 12.0 | -3.73 % | $ 193 M | USA |
 |
Evolent Health
EVH
|
$ 4.79 | 1.7 % | $ 547 M | USA |
 |
GoodRx Holdings
GDRX
|
$ 3.54 | -3.01 % | $ 1.26 B | USA |
 |
Castlight Health, Inc.
CSLT
|
- | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
- | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
- | - | $ 6.37 B | USA |
 |
Health Catalyst
HCAT
|
$ 1.46 | -3.31 % | $ 102 M | USA |
 |
HealthEquity
HQY
|
$ 103.68 | 1.53 % | $ 8.93 B | USA |
 |
Omnicell
OMCL
|
$ 35.87 | -3.96 % | $ 1.65 B | USA |
 |
Progyny
PGNY
|
$ 36.44 | 1.35 % | $ 3.11 B | USA |
 |
Schrödinger
SDGR
|
$ 32.42 | -2.89 % | $ 2.38 B | USA |
 |
Teladoc Health
TDOC
|
$ 8.96 | -0.28 % | $ 1.58 B | USA |
 |
Computer Programs and Systems
CPSI
|
- | 4.4 % | $ 133 M | USA |
 |
Phreesia
PHR
|
$ 13.15 | 1.94 % | $ 786 M | USA |
 |
Akerna Corp.
KERN
|
- | - | $ 161 M | USA |
 |
MTBC
MTBC
|
- | -0.58 % | $ 51.7 M | USA |
 |
Premier
PINC
|
- | - | $ 2.33 B | USA |
 |
Streamline Health Solutions
STRM
|
- | - | $ 21.4 M | USA |
 |
Signify Health
SGFY
|
- | -0.02 % | $ 7.21 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
- | - | $ 255 M | USA |
 |
OptimizeRx Corporation
OPRX
|
$ 9.34 | -1.37 % | $ 173 M | USA |
 |
Change Healthcare
CHNG
|
- | - | $ 9.03 B | USA |
 |
Cerner Corporation
CERN
|
- | - | $ 27.9 B | USA |
 |
10x Genomics
TXG
|
$ 62.88 | -3.34 % | $ 7.84 B | USA |
 |
Veeva Systems
VEEV
|
$ 306.1 | -0.1 % | $ 50.1 B | USA |
 |
SCWorx Corp.
WORX
|
$ 1.31 | -5.76 % | $ 9.53 M | USA |
 |
Zhongchao
ZCMD
|
$ 0.94 | -5.99 % | $ 3.21 M | China |
 |
HealthStream
HSTM
|
$ 28.69 | -0.14 % | $ 861 M | USA |
 |
Accolade
ACCD
|
- | 0.29 % | $ 206 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
- | -10.39 % | $ 886 M | USA |
 |
NantHealth
NH
|
- | -46.64 % | $ 10.4 M | USA |
 |
Covetrus
CVET
|
- | - | $ 2.94 B | USA |
 |
NextGen Healthcare
NXGN
|
- | - | $ 1.6 B | USA |